Risk factor
Critical default risk
Profitability factor
Greatly undervalued vs peers
About
UV Flu Technologies, Inc., headquartered in Lincolnshire, Illinois, focuses on the research, development, production, and distribution of air purification systems and products, primarily serving the United States market. Its signature product, the ViraTech UV-400, incorporates intense germicidal ultraviolet radiation within a specialized chamber. This advanced system goes beyond simple filtration by actively capturing and eliminating hazardous microbes. Additionally, the company offers the RX Air product line, which comprises air purifiers based on HEPA technology. These solutions are employed across a wide array of environments, including hotels, hair and nail salons, pet kennels, testing laboratories, hospitals, dining establishments, casinos, and military facilities. Founded in 2006, the enterprise initially operated under the name Northwest Chariots Incorporated before officially becoming UV Flu Technologies, Inc. in November 2009.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks.